Antidepressant withdrawal often mimics relapse; learn why hyperbolic tapering, informed consent, and slow cut-and-hold deprescribing reduce harm.
Camila Losada Strassle, JD
Advertisement
Ms Strassle was formerly an Assistant Chief Counsel at the Office of the Chief Counsel for the US Food and Drug Administration.
Articles by Camila Losada Strassle, JD
Advertisement
Latest Updated Articles
Exiting Antidepressants: A Needed Spotlight on WithdrawalFebruary 9th 2026
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Endangered Education: Psychiatric Professional Degrees Under Attack
5